載入...

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.

The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Harris, A. L., Dowsett, M., Smith, I. E., Jeffcoate, S. L.
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 1983
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2011397/
https://ncbi.nlm.nih.gov/pubmed/6221746
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!